Gulzhanat Aimagambetova is an expert in Obstetrics at Nazarbayev University (Kazakhstan). Gulzhanat Aimagambetova has authored 95 publications, the most recent in 2026, and is an investigator in 1 clinical trial, 1 of them ongoing. SLR score: 324 (community average: 125). How the SLR is computed.

LeadR Profile

Gulzhanat Aimagambetova Nazarbayev University Kazakhstan
324 ScienceLeadR Reputation 324
Network Map

Obstetrics

Subspecialties: Infectiology - Public Health - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2015 - 2026

Source: PubMed

Nazarbayev University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 95

Citations

Citations: 1 652 1st author: 20 Last author: 16 Unique author: 2


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Next-Generation Pharmacotherapy for Uterine Leiomyomas: Combining Metformin and Ulipristal Acetate as Neoadjuvant and Adjuvant Interventions to Minimally Invasive Procedures.
PMID 42942262 — menorrhagia, hemorrhage, pharmaceutical preparations, acetates, drug therapy, liver, leiomyoma, therapeutics, metformin
Life (Basel)20260
Cervicovaginal microbiome alterations across HPV infection.
PMID 42834904 — cell biology, alphapapillomavirus, papillomavirus infections, infections, human papillomavirus viruses
Front Cell Infect Microbiol20260
Multi-kingdom cervical microbiome structure in health and dysbiosis: a cross-sectional study from Kazakhstan.
PMID 42577453 — dysbiosis, cross-sectional studies, multiple chronic conditions, archaea, infections
Front Microbiol20261
Abdominal Aorta Balloon Occlusion Versus Standard Care in Placenta Accreta Spectrum Disorder: A Randomized Controlled Trial.
PMID 42514175 — aorta, abdominal, blood, hysterectomy, aorta, placenta accreta, operative time, intensive care units, placenta, balloon occlusion
Life (Basel)20260
Tiered Functional Screening Identifies an Autochthonous Vaginal Lactiplantibacillus plantarum Strain with Probiotic Potential.
PMID 42514031 — tissue adhesions, gentian violet, lactobacillales, workflow, neoplasms, genome, biofilms, lactic acid, work, probiotics, alphapapillomavirus, retention, psychology, bacteria, human papillomavirus viruses, shotgun sequencing
Microorganisms20261

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Not yet recruiting 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Effectiveness of REBOA in Reducing Blood Loss During Cesarean Section in Patients with PAS
NCT06721182 — tertiary care centers, hemorrhage, blood, hysterectomy, aorta, placenta accreta, placenta previa, intensive care units, tertiary healthcare, cesarean section, placenta, balloon occlusion
N/ANot yet recruiting2024

LeadR Networks

Main global connection map